博思軟件(300525.SZ):擬向博思雲易增資510萬元
格隆匯5月11日丨博思軟件(300525.SZ)公佈,為增強福建博思雲易智能科技有限公司(簡稱“博思雲易”)資金實力,促進其業務的穩步開展,公司擬使用自有或自籌資金510.00萬元向博思雲易增資,認繳博思雲易新增註冊資本510.00萬元。同時,持有博思雲易49%股權的員工持股平台福州高新區博醫同創智能科技合夥企業(有限合夥)(簡稱“博醫同創”)同比例增資。本次增資完成後,博思雲易註冊資本由人民幣1000.00萬元增加至人民幣2000.00萬元,公司仍持有博思雲易51%股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.